Redefine statistical significance by Benjamin, Daniel J et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Redefine statistical significance
Citation for published version:
Benjamin, DJ, Berger, JO, Johannesson, M, Nosek, BA, Wagenmakers, E-J, Berk, R, Bollen, KA, Brembs,
B, Brown, L, Camerer, C, Cesarini, D, Chambers, CD, Clyde, M, Cook, TD, De Boeck, P, Dienes, Z, Dreber,
A, Easwaran, K, Efferson, C, Fehr, E, Fidler, F, Field, AP, Forster, M, George, EI, Gonzalez, R, Goodman,
S, Green, E, Green, DP, Greenwald, AG, Hadfield, JD, Hedges, LV, Held, L, Hua Ho, T, Hoijtink, H,
Hruschka, DJ, Imai, K, Imbens, G, Ioannidis, JPA, Jeon, M, Jones, JH, Kirchler, M, Laibson, D, List, J, Little,
R, Lupia, A, Machery, E, Maxwell, SE, McCarthy, M, Moore, DA, Morgan, SL, Munafó, M, Nakagawa, S,
Nyhan, B, Parker, TH, Pericchi, L, Perugini, M, Rouder, J, Rousseau, J, Savalei, V, Schönbrodt, FD, Sellke,
T, Sinclair, B, Tingley, D, Van Zandt, T, Vazire, S, Watts, DJ, Winship, C, Wolpert, RL, Xie, Y, Young, C,
Zinman, J & Johnson, VE 2018, 'Redefine statistical significance', Nature Human Behaviour, vol. 2, no. 1,
pp. 6-10. https://doi.org/10.1038/s41562-017-0189-z
Digital Object Identifier (DOI):
10.1038/s41562-017-0189-z
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Nature Human Behaviour
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 26. Sep. 2019
	 1	
Title:  Redefine Statistical Significance  
Authors: Daniel J. Benjamin1*, James O. Berger2, Magnus Johannesson3*, Brian A. 
Nosek4,5, E.-J. Wagenmakers6, Richard Berk7, 10, Kenneth A. Bollen8, Björn Brembs9, 
Lawrence Brown10, Colin Camerer11, David Cesarini12, 13, Christopher D. Chambers14, 
Merlise Clyde2, Thomas D. Cook15,16, Paul De Boeck17, Zoltan Dienes18, Anna Dreber3, 
Kenny Easwaran19, Charles Efferson20, Ernst Fehr21, Fiona Fidler22, Andy P. Field18, 
Malcolm Forster23, Edward I. George10, Richard Gonzalez24, Steven Goodman25, Edwin 
Green26, Donald P. Green27, Anthony Greenwald28, Jarrod D. Hadfield29, Larry V. 
Hedges30, Leonhard Held31, Teck Hua Ho32, Herbert Hoijtink33, James Holland 
Jones39,40, Daniel J. Hruschka34, Kosuke Imai35, Guido Imbens36, John P.A. Ioannidis37, 
Minjeong Jeon38, Michael Kirchler41, David Laibson42, John List43, Roderick Little44, 
Arthur Lupia45, Edouard Machery46, Scott E. Maxwell47, Michael McCarthy48, Don 
Moore49, Stephen L. Morgan50, Marcus Munafó51, 52, Shinichi Nakagawa53, Brendan 
Nyhan54, Timothy H. Parker55, Luis Pericchi56, Marco Perugini57, Jeff Rouder58, Judith 
Rousseau59, Victoria Savalei60, Felix D. Schönbrodt61, Thomas Sellke62, Betsy 
Sinclair63, Dustin Tingley64, Trisha Van Zandt65, Simine Vazire66, Duncan J. Watts67, 
Christopher Winship68, Robert L. Wolpert2, Yu Xie69, Cristobal Young70, Jonathan 
Zinman71, Valen E. Johnson72* 
 
Affiliations: 
1Center for Economic and Social Research and Department of Economics, University of 
Southern California, Los Angeles, CA 90089-3332, USA. 
2Department of Statistical Science, Duke University, Durham, NC 27708-0251, USA. 
3Department of Economics, Stockholm School of Economics, SE-113 83 Stockholm, 
Sweden. 
4University of Virginia, Charlottesville, VA 22908, USA. 
5Center for Open Science, Charlottesville, VA 22903, USA. 
6University of Amsterdam, Department of Psychology, 1018 VZ Amsterdam, The 
Netherlands. 
7University of Pennsylvania, School of Arts and Sciences and Department of 
Criminology, Philadelphia, PA 19104-6286, USA. 
8University of North Carolina Chapel Hill, Department of Psychology and Neuroscience, 
Department of Sociology, Chapel Hill, NC 27599-3270, USA. 
9Institute of Zoology - Neurogenetics, Universität Regensburg, Universitätsstrasse 31 
93040 Regensburg, Germany. 
	 2	
10Department of Statistics, The Wharton School, University of Pennsylvania, 
Philadelphia, PA 19104, USA. 
11Division of the Humanities and Social Sciences, California Institute of Technology, 
Pasadena, CA 91125, USA. 
12Department of Economics, New York University, New York, NY 10012, USA. 
13The Research Institute of Industrial Economics (IFN), SE- 102 15 Stockholm, Sweden. 
14Cardiff University Brain Research Imaging Centre (CUBRIC), CF24 4HQ, UK. 
15Northwestern University, Evanston, IL 60208, USA. 
16Mathematica Policy Research, Washington, DC, 20002-4221, USA. 
17Department of Psychology, Quantitative Program, Ohio State University, Columbus, 
OH 43210, USA. 
18School of Psychology, University of Sussex, Brighton BN1 9QH, UK. 
19Department of Philosophy, Texas A&M University, College Station, TX 77843-4237, 
USA. 
20Department of Psychology, Royal Holloway University of London, Egham Surrey 
TW20 0EX, UK. 
21Department of Economics, University of Zurich, 8006 Zurich, Switzerland. 
22School of BioSciences and School of Historical & Philosophical Studies, University of 
Melbourne, Vic 3010, Australia. 
23Department of Philosophy, University of Wisconsin - Madison, Madison, WI 53706, 
USA. 
24Department of Psychology, University of Michigan, Ann Arbor, MI 48109-1043, USA. 
25Stanford University, General Medical Disciplines, Stanford, CA 94305, USA. 
26Department of Ecology, Evolution and Natural Resources SEBS, Rutgers University, 
New Brunswick, NJ 08901-8551, USA. 
27Department of Political Science, Columbia University in the City of New York, New 
York, NY 10027, USA. 
28Department of Psychology, University of Washington, Seattle, WA 98195-1525, USA. 
29Institute of Evolutionary Biology School of Biological Sciences, The University of 
Edinburgh, Edinburgh EH9 3JT, UK. 
	 3	
30Weinberg College of Arts & Sciences Department of Statistics, Northwestern 
University, Evanston, IL 60208, USA. 
31Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, 
8001 Zurich, Switzerland. 
32National University of Singapore, Singapore 119077. 
33Department of Methods and Statistics, Universiteit Utrecht, 3584 CH Utrecht, The 
Netherlands. 
34School of Human Evolution and Social Change, Arizona State University, Tempe, AZ 
85287-2402, USA. 
35Department of Politics and Center for Statistics and Machine Learning, Princeton 
University, Princeton NJ 08544, USA. 
36Stanford University, Stanford, CA 94305-5015, USA. 
37Departments of Medicine, of Health Research and Policy, of Biomedical Data 
Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), 
Stanford University, Stanford, CA 94305, USA. 
38 Advanced Quantitative Methods, Social Research Methodology, Department of 
Education, Graduate School of Education & Information Studies, University of 
California, Los Angeles, CA 90095-1521, USA. 
39Department of Life Sciences, Imperial College London, Ascot SL5 7PY, UK. 
40Department of Earth System Science, Stanford, CA 94305- 4216, USA. 
41Department of Banking and Finance, University of Innsbruck and University of 
Gothenburg, A-6020 Innsbruck, Austria. 
42Department of Economics, Harvard University, Cambridge, MA 02138, USA. 
43Department of Economics, University of Chicago, Chicago, IL 60637, USA. 
44Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109-2029, USA. 
45Department of Political Science, University of Michigan, Ann Arbor, MI 48109-1045, 
USA. 
46Department of History and Philosophy of Science, University of Pittsburgh, Pittsburgh 
PA 15260, USA. 
47Department of Psychology, University of Notre Dame, Notre Dame, IN 46556, USA. 
48School of BioSciences, University of Melbourne, Vic 3010, Australia. 
	 4	
49Haas School of Business, University of California at Berkeley, Berkeley, CA 94720-
1900A, USA. 
50Johns Hopkins University, Baltimore, MD 21218, USA. 
51MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 1TU, UK. 
52UK Centre for Tobacco and Alcohol Studies, School of Experimental Psychology, 
University of Bristol, Bristol BS8 1TU, UK. 
53Evolution & Ecology Research Centre and School of Biological, Earth and 
Environmental Sciences, University of New South Wales, Sydney, NSW 2052, Australia. 
54Department of Government, Dartmouth College, Hanover, NH 03755, USA. 
55Department of Biology, Whitman College, Walla Walla, WA 99362, USA. 
56Department of Mathematics, University of Puerto Rico, Rio Piedras Campus, San 
Juan, PR 00936-8377. 
57Department of Psychology, University of Milan - Bicocca, 20126 Milan, Italy. 
58Department of Psychological Sciences, University of Missouri, Columbia, MO 65211, 
USA. 
59Université Paris Dauphine, 75016 Paris, France. 
60Department of Psychology, The University of British Columbia, Vancouver, BC Canada 
V6T 1Z4. 
61Department Psychology, Ludwig-Maximilians-University Munich, Leopoldstraße 13, 
80802 Munich, Germany. 
62Department of Statistics, Purdue University, West Lafayette, IN 47907-2067, USA. 
63Department of Political Science, Washington University in St. Louis, St. Louis, MO 
63130-4899, USA. 
64Government Department, Harvard University, Cambridge, MA 02138, USA. 
65Department of Psychology, Ohio State University, Columbus, OH 43210, USA. 
66Department of Psychology, University of California, Davis, CA, 95616, USA. 
67Microsoft Research. 641 Avenue of the Americas, 7th Floor, New York, NY 10011, 
USA. 
68Department of Sociology, Harvard University, Cambridge, MA 02138, USA. 
69Department of Sociology, Princeton University, Princeton NJ 08544, USA. 
70Department of Sociology, Stanford University, Stanford, CA 94305-2047, USA. 
	 5	
71Department of Economics, Dartmouth College, Hanover, NH 03755-3514, USA. 
72Department of Statistics, Texas A&M University, College Station, TX 77843, USA. 
*Correspondence to:  Daniel J. Benjamin, daniel.benjamin@gmail.com; Magnus 
Johannesson, magnus.johannesson@hhs.se; Valen E. Johnson, 
vejohnson@exchange.tamu.edu. 
 
One Sentence Summary: We propose to change the default P-value threshold for 
statistical significance for claims of new discoveries from 0.05 to 0.005. 
 
 
Main Text:  
The lack of reproducibility of scientific studies has caused growing concern over 
the credibility of claims of new discoveries based on “statistically significant” findings. 
There has been much progress toward documenting and addressing several causes of this 
lack of reproducibility (e.g., multiple testing, P-hacking, publication bias, and under-
powered studies). However, we believe that a leading cause of non-reproducibility has 
not yet been adequately addressed: Statistical standards of evidence for claiming new 
discoveries in many fields of science are simply too low. Associating “statistically 
significant” findings with P < 0.05 results in a high rate of false positives even in the 
absence of other experimental, procedural and reporting problems. 
For fields where the threshold for defining statistical significance for new 
discoveries is 𝑃 < 0.05, we propose a change to 𝑃 < 0.005. This simple step would 
immediately improve the reproducibility of scientific research in many fields. Results that 
would currently be called “significant” but do not meet the new threshold should instead 
be called “suggestive.” While statisticians have known the relative weakness of using 𝑃 ≈ 0.05 as a threshold for discovery and the proposal to lower it to 0.005 is not new (1, 
2), a critical mass of researchers now endorse this change. 
We restrict our recommendation to claims of discovery of new effects. We do not 
address the appropriate threshold for confirmatory or contradictory replications of 
existing claims. We also do not advocate changes to discovery thresholds in fields that 
have already adopted more stringent standards (e.g., genomics and high-energy physics 
research; see Potential Objections below). 
We also restrict our recommendation to studies that conduct null hypothesis 
significance tests. We have diverse views about how best to improve reproducibility, and 
many of us believe that other ways of summarizing the data, such as Bayes factors or 
other posterior summaries based on clearly articulated model assumptions, are preferable 
to P-values. However, changing the P-value threshold is simple, aligns with the training 
undertaken by many researchers, and might quickly achieve broad acceptance.    
 
 Strength of evidence from P-values 
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 In testing a point null hypothesis 𝐻! against an alternative hypothesis 𝐻! based on 
data 𝑥obs, the P-value is defined as the probability, calculated under the null hypothesis, 
that a test statistic is as extreme or more extreme than its observed value. The null 
hypothesis is typically rejected—and the finding is declared “statistically significant”—if 
the P-value falls below the (current) Type I error threshold α = 0.05. 	 From a Bayesian perspective,	a more direct measure of the strength of evidence 
for 𝐻! relative to 𝐻! is the ratio of their probabilities. By Bayes’ rule, this ratio may be 
written as: 		 Pr 𝐻!|𝑥obsPr 𝐻!|𝑥obs = 𝑓 𝑥obs|𝐻!𝑓 𝑥obs|𝐻! × Pr 𝐻!Pr 𝐻! ≡ 𝐵𝐹 × prior odds ,	 (1)		
where 𝐵𝐹 is the Bayes factor that represents the evidence from the data, and the prior 
odds can be informed by researchers’ beliefs, scientific consensus, and validated 
evidence from similar research questions in the same field. Multiple hypothesis testing, 
P-hacking, and publication bias all reduce the credibility of evidence. Some of these 
practices reduce the prior odds of 𝐻! relative to 𝐻! by changing the population of 
hypothesis tests that are reported. Prediction markets (3) and analyses of replication 
results (4) both suggest that for psychology experiments, the prior odds of 𝐻! relative to 𝐻! may be only about 1:10. A similar number has been suggested in cancer clinical trials, 
and the number is likely to be much lower in preclinical biomedical research (5).  
There is no unique mapping between the P-value and the Bayes factor since the 
Bayes factor depends on 𝐻!. However, the connection between the two quantities can be 
evaluated for particular test statistics under certain classes of plausible alternatives (Fig. 
1). 
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Fig. 1. Relationship between the P-value and the Bayes Factor. The Bayes factor (BF) 
is defined as ! !obs|!!! !obs|!! . The figure assumes that observations are drawn i.i.d. according to 𝑥 ~ 𝑁 𝜇,𝜎! , where the mean 𝜇 is unknown and the variance 𝜎! is known.  The P-value 
is from a two-sided z test (or equivalently a one-sided 𝜒! !  test) of the null hypothesis 𝐻!: 𝜇 = 0. 
“Power”: BF obtained by defining 𝐻! as putting ½ probability on 𝜇 = ±𝑚 for the value 
of 𝑚 that gives 75% power for the test of size α = 0.05. This 𝐻! represents an effect size 
typical of that which is implicitly assumed by researchers during experimental design. 
“Likelihood Ratio Bound”: BF obtained by defining 𝐻! as putting ½ probability on 𝜇 = ±𝑥, where 𝑥 is approximately equal to the mean of the observations. These BFs are 
upper bounds among the class of all 𝐻!’s that are symmetric around the null, but they are 
improper because the data are used to define 𝐻!. “UMPBT”: BF obtained by defining 𝐻! 
according to the uniformly most powerful Bayesian test (5) that places ½ probability on 𝜇 = ±𝑤, where 𝑤 is the alternative hypothesis that corresponds to a one-sided test of size 
0.0025.  This curve is indistinguishable from the “Power” curve that would be obtained if 
the power used in its definition was 80% rather than 75%. “Local-𝐻! Bound”: BF =!!!" !"!, where 𝑝 is the P-value, is a large-sample upper bound on the BF from among all 
unimodal alternative hypotheses that have a mode at the null and satisfy certain regularity 
conditions (15). For more details, see the Supplementary Online Materials (SOM). 
 
A two-sided P-value of 0.05 corresponds to Bayes factors in favor of 𝐻! that range from 
about 2.5 to 3.4 under reasonable assumptions about 𝐻! (Fig. 1). This is weak evidence 
from at least three perspectives. First, conventional Bayes factor categorizations (6) 
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characterize this range as “weak” or “very weak.” Second, we suspect many scientists 
would guess that 𝑃 ≈ 0.05 implies stronger support for 𝐻! than a Bayes factor of 2.5 to 
3.4. Third, using equation (1) and prior odds of 1:10, a P-value of 0.05 corresponds to at 
least 3:1 odds (i.e., the reciprocal of the product !!"× 3.4) in favor of the null hypothesis! 
 
Why 0.005? 
 The choice of any particular threshold is arbitrary and involves a trade-off 
between Type I and II errors. We propose 0.005 for two reasons. First, a two-sided P-
value of 0.005 corresponds to Bayes factors between approximately 14 and 26 in favor of 𝐻!. This range represents “substantial” to “strong” evidence according to conventional 
Bayes factor classifications (6). 
 Second, in many fields the 𝑃 < 0.005 standard would reduce the false positive 
rate to levels we judge to be reasonable. If we let 𝜙 denote the proportion of null 
hypotheses that are true, (1− 𝛽) the power of tests in rejecting false null hypotheses, and 𝛼 the Type I error/significance threshold, then as the population of tested hypotheses 
becomes large, the false positive rate (i.e., the proportion of true null effects among the 
total number of statistically significant findings) can be approximated by  		 false positive rate ≈  𝛼𝜙𝛼𝜙 + (1− 𝛽)(1− 𝜙).	 (2)	
 
For different levels of the prior odds that there is a true effect, !!!! , and for significance 
thresholds 𝛼 = 0.05 and 𝛼 = 0.005, Figure 2 shows the false positive rate as a function 
of power 1− 𝛽. 
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Fig. 2. Relationship between the P-value threshold, power, and the false positive 
rate. Calculated according to Equation (2), with prior odds defined as !!!! = !" !!!"(!!). For 
more details, see the Supplementary Online Materials (SOM). 
 
In many studies, statistical power is low (e.g., ref. 7). Fig. 2 demonstrates that low 
statistical power and 𝛼 = 0.05 combine to produce high false positive rates. 
 For many, the calculations illustrated by Fig. 2 may be unsettling. For example, 
the false positive rate is greater than 33% with prior odds of 1:10 and a P-value threshold 
of 0.05, regardless of the level of statistical power. Reducing the threshold to 0.005 
would reduce this minimum false positive rate to 5%. Similar reductions in false positive 
rates would occur over a wide range of statistical powers. 
Empirical evidence from recent replication projects in psychology and 
experimental economics provide insights into the prior odds in favor of 𝐻!. In both 
projects, the rate of replication (i.e., significance at P < 0.05 in the replication in a 
consistent direction) was roughly double for initial studies with P < 0.005 relative to 
initial studies with 0.005 < P < 0.05: 50% versus 24% for psychology (8), and 85% 
versus 44% for experimental economics (9). Although based on relatively small samples 
of studies (93 in psychology, 16 in experimental economics, after excluding initial studies 
with P > 0.05), these numbers are suggestive of the potential gains in reproducibility that 
would accrue from the new threshold of P < 0.005 in these fields. In biomedical research, 
96% of a sample of recent papers claim statistically significant results with the P < 0.05 
threshold (10). However, replication rates were very low (5)  for these studies, suggesting 
a potential for gains by adopting this new standard in these fields as well. 
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Potential Objections 
 We now address the most compelling arguments against adopting this higher 
standard of evidence. 
  The false negative rate would become unacceptably high. Evidence that does not 
reach the new significance threshold should be treated as suggestive, and where possible  
further evidence should be accumulated; indeed, the combined results from several 
studies may be compelling even if any particular study is not. Failing to reject the null 
hypothesis does not mean accepting the null hypothesis. Moreover, the false negative rate 
will not increase if sample sizes are increased so that statistical power is held constant.   
For a wide range of common statistical tests, transitioning from a P-value 
threshold of 𝛼 = 0.05 to 𝛼 = 0.005 while maintaining 80% power would require an 
increase in sample sizes of about 70%. Such an increase means that fewer studies can be 
conducted using current experimental designs and budgets. But Figure 2 shows the 
benefit: false positive rates would typically fall by factors greater than two. Hence, 
considerable resources would be saved by not performing future studies based on false 
premises. Increasing sample sizes is also desirable because studies with small sample 
sizes tend to yield inflated effect size estimates (11), and publication and other biases 
may be more likely in an environment of small studies (12). We believe that efficiency 
gains would far outweigh losses. 
The proposal does not address multiple hypothesis testing, P-hacking, publication 
bias, low power, or other biases (e.g., confounding, selective reporting, measurement 
error), which are arguably the bigger problems. We agree. Reducing the P-value 
threshold complements—but does not substitute for—solutions to these other problems, 
which include good study design, ex ante power calculations, pre-registration of planned 
analyses, replications, and transparent reporting of procedures and all statistical analyses 
conducted.  
The appropriate threshold for statistical significance should be different for 
different research communities. We agree that the significance threshold selected for 
claiming a new discovery should depend on the prior odds that the null hypothesis is true, 
the number of hypotheses tested, the study design, the relative cost of Type I versus Type 
II errors, and other factors that vary by research topic. For exploratory research with very 
low prior odds (well outside the range in Figure 2), even lower significance thresholds 
than 0.005 are needed. Recognition of this issue led the genetics research community to 
move to a “genome-wide significance threshold” of 5×10-8 over a decade ago. And in 
high-energy physics, the tradition has long been to define significance by a “5-sigma” 
rule (roughly a P-value threshold of 3×10-7). We are essentially suggesting a move from a 
2-sigma rule to a 3-sigma rule. 
 Our recommendation applies to disciplines with prior odds broadly in the range 
depicted in Figure 2, where use of P < 0.05 as a default is widespread. Within those 
disciplines, it is helpful for consumers of research to have a consistent benchmark. We 
feel the default should be shifted. 
	 11	
Changing the significance threshold is a distraction from the real solution, which 
is to replace null hypothesis significance testing (and bright-line thresholds) with more 
focus on effect sizes and confidence intervals, treating the P-value as a continuous 
measure, and/or a Bayesian method. Many of us agree that there are better approaches to 
statistical analyses than null hypothesis significance testing, but as yet there is no 
consensus regarding the appropriate choice of replacement. For example, a recent 
statement by the American Statistical Association addressed numerous issues regarding 
the misinterpretation and misuse of P-values (as well as the related concept of statistical 
significance), but failed to make explicit policy recommendations to address these 
shortcomings (13) . Even after the significance threshold is changed, many of us will 
continue to advocate for alternatives to null hypothesis significance testing.   
 
Concluding remarks 
Ronald Fisher understood that the choice of 0.05 was arbitrary when he 
introduced it (14).  Since then, theory and empirical evidence have demonstrated that a 
lower threshold is needed. A much larger pool of scientists are now asking a much larger 
number of questions, possibly with much lower prior odds of success.   
For research communities that continue to rely on null hypothesis significance 
testing, reducing the P-value threshold for claims of new discoveries to 0.005 is an 
actionable step that will immediately improve reproducibility.  We emphasize that this 
proposal is about standards of evidence, not standards for policy action nor standards for 
publication.  Results that do not reach the threshold for statistical significance (whatever 
it is) can still be important and merit publication in leading journals if they address 
important research questions with rigorous methods. This proposal should not be used to 
reject publications of novel findings with 0.005 < P < 0.05 properly labeled as suggestive 
evidence. We should reward quality and transparency of research as we impose these 
more stringent standards, and we should monitor how researchers’ behaviors are affected 
by this change. Otherwise, science runs the risk that the more demanding threshold for 
statistical significance will be met to the detriment of quality and transparency. 
 Journals can help transition to the new statistical significance threshold. Authors 
and readers can themselves take the initiative by describing and interpreting results more 
appropriately in light of the new proposed definition of “statistical significance.” The 
new significance threshold will help researchers and readers to understand and 
communicate evidence more accurately. 	
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Figure 1  
All four curves in Figure 1 describe the relationship between (i) a P-value based 
on a two-sided normal test and (ii) a Bayes factor or a bound on a Bayes factor.  The P-
values are based on a two-sided test that the mean 𝜇 of an independent and identically 
distributed sample of normally distributed random variables is 0.  The variance of the 
observations is known.  Without loss of generality, we assume that the variance is 1 and 
the sample size is also 1.  The curves in the figure differ according to the alternative 
hypotheses that they assume for calculating (ii). 
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Because these curves involve two-sided tests, all alternative hypotheses are restricted to 
be symmetric around 0.   That is, the density assumed for the value of 𝜇 under the 
alternative hypothesis is always assumed to satisfy 𝑓 𝜇 = 𝑓 −𝜇 . 
The curve labeled “Power” corresponds to defining the alternative hypothesis so that 
power is 75% in a two-sided 5% test.  This is achieved by assuming that 𝜇 under the 
alternative hypothesis is equal to ± 𝑧!.!"# + 𝑧!.!" = ±2.63.  That is, the alternative 
hypothesis places ½ its prior mass on 2.63 and ½ its mass on -2.63.   
The curve labeled UMPBT corresponds to the uniformly most powerful Bayesian test (2) 
that corresponds to a classical, two-sided test of size 𝛼 = 0.005.  The alternative 
hypothesis for this Bayesian test places ½ mass at 2.81 and ½ mass at -2.81.   The null 
hypothesis for this test is rejected if the Bayes factor exceeds 25.7.  Note that this curve is 
nearly identical to the “Power” curve if that curve had been defined using 80% power, 
rather than 75% power.  The Power curve for 80% power would place ½ its mass at ±2.80. 
The Likelihood Ratio Bound curve represents an approximate upper bound on the Bayes 
factor obtained by defining the alternative hypothesis as putting ½ its mass on ±𝑥, where 𝑥 is the observed sample mean.  Over the range of P-values displayed in the figure, this 
alternative hypothesis very closely approximates the maximum Bayes factor that can be 
attained from among the set of alternative hypotheses constrained to be of the form 0.5×[𝑓 𝜇 + 𝑓 −𝜇 ] for some density function f. 
The Local-H1 curve is described fully in the figure caption.	A	fuller	explanation	and	discussion	of	this	bound	can	be	found	in	ref.	15. 
 
Equation 2 and Figure 2   
This equation defines the large-sample relationship between the false positive 
rate, power 1− 𝛽, type I error rate 𝛼, and the probability that the null hypothesis is true 
when a large number of independent experiments have been conducted.  More 
specifically, suppose that n independent hypothesis tests are conducted, and suppose that 
in each test the probability that the null hypothesis is true is 𝜙.   If the null hypothesis is 
true, assume that the probability that it is falsely rejected (i.e., a false positive occurs) is 𝛼.  For the test 𝑗 = 1,… ,𝑛, define the random variable 𝑋! = 1 if the null hypothesis is 
true and the null hypothesis is rejected, and 𝑋! = 0 if either the alternative hypothesis is 
true or the null hypothesis is not rejected.  Note that the 𝑋! are independent Bernoulli 
random variables with Pr 𝑋! = 1 = 𝛼𝜙.  Also for test j, define another random variable 𝑌! = 1 if the alternative hypothesis is true and the null hypothesis is rejected, and 0 
otherwise.   It follows that the 𝑌! are independent Bernoulli random variables with Pr 𝑌! = 1 = 1− 𝜙 1− 𝛽 .  Note that 𝑌! is independent of 𝑌! for 𝑗 ≠ 𝑘, but 𝑌! is not 
independent of 𝑋!.  For the n experiments, the false positive rate can then be written as: 
 𝐹𝑃𝑅 =  𝑋!!!!!𝑋! + 𝑌!!!!!!!!! = 𝑋!/𝑛!!!!𝑋!/𝑛 + 𝑌!/𝑛!!!!!!!! . 
	 14	
 
By the strong law of large numbers, 𝑋!/𝑛!!!!  converges almost surely to 𝛼𝜙, and 𝑌!/𝑛!!!!  converges almost surely to 1− 𝜙 1− 𝛽 .  Application of the continuous 
mapping theorem yields 
 𝐹𝑃𝑅 a.s.  𝛼𝜙𝛼𝜙 + (1− 𝜙)(1− 𝛽). 
 
Figure 2 illustrates this relationship for various values of 𝛼 and prior odds for the 
alternative, !!!! . 
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R code used to generate Figure 1: 
 
type1=.005 
type1Power=0.05 
type2=0.25 
p=1-c(9000:9990)/10000 
xbar = qnorm(1-p/2) 
 
# alternative based on 80% POWER IN 5% TEST 
muPower = qnorm(1-type2)+qnorm(1-type1Power/2) 
bfPow = 0.5*(dnorm(xbar,muPower,1)+dnorm(xbar,-
muPower,1))/dnorm(xbar,0,1) 
 
muUMPBT = qnorm(0.9975) 
bfUMPBT = 0.5*(dnorm(xbar,muUMPBT,1)+dnorm(xbar,-
muUMPBT,1))/dnorm(xbar,0,1) 
 
# two-sided "LR" bound 
bfLR = 0.5/exp(-0.5*xbar^2) 
 
bfLocal = -1/(2.71*p*log(p)) 
 
#coordinates for dashed lines 
data = data.frame(p,bfLocal,bfLR,bfPow,bfUMPBT) 
U_005 = max(data$bfLR[data$p=="0.005"]) 
L_005 = min(data$bfLocal[data$p=="0.005"]) 
U_05 = max(data$bfLR[data$p=="0.05"]) 
L_05 = min(data$bfUMPBT[data$p=="0.05"]) 
 
# Local bound; no need for two-sided adjustment 
 
 
#plot margins 
par(mai=c(0.8,0.8,.1,0.4)) 
par(mgp=c(2,1,0)) 
 
matplot(p,cbind(bfLR,-1/(2.71*p*log(p))),type='n',log='xy', 
        xlab=expression(paste(italic(P) ,"-value")), 
        ylab="Bayes Factor", 
        ylim = c(0.3,100), 
        bty="n",xaxt="n",yaxt="n") 
lines(p,bfPow,col="red",lwd=2.5) 
lines(p,bfLR,col="black",lwd=2.5) 
lines(p,bfUMPBT,col="blue",lwd=2.5) 
lines(p,bfLocal,col="green",lwd=2.5) 
legend(0.015,100,c(expression(paste("Power")),"Likelihood Ratio 
Bound","UMPBT",expression(paste("Local-",italic(H)[1]," 
Bound"))),lty=c(1,1,1,1), 
       lwd=c(2.5,2.5,2.5,2.5),col=c("red","black","blue","green"), 
cex = 0.8) 
#text(0.062,65, "\u03B1", font =3, cex = 0.9) 
 
#customizing axes 
#x axis 
	 16	
axis(side=1,at=c(-
2,0.001,0.0025,0.005,0.010,0.025,0.050,0.100,0.14), 
     labels = 
c("","0.0010","0.0025","0.0050","0.0100","0.0250","0.0500","0.1000",
""),lwd=1, 
     tck = -0.01, padj = -1.1, cex.axis = .8) 
#y axis on the left - main 
axis(side=2,at=c(-0.2, 0.3,0.5,1,2,5,10,20,50,100),labels = 
c("","0.3","0.5","1.0","2.0","5.0","10.0","20.0","50.0","100.0"),lwd
=1,las= 1, 
     tck = -0.01, hadj = 0.6, cex.axis = .8) 
#y axis on the left - secondary (red labels) 
axis(side=2,at=c(L_005,U_005),labels = c(13.9,25.7),lwd=1,las= 1, 
     tck = -0.01, hadj = 0.6, cex.axis = .6,col.axis="red") 
#y axis on the right - main 
axis(side=4,at=c(-0.2, 0.3,0.5,1,2,5,10,20,50,100),labels = 
c("","0.3","0.5","1.0","2.0","5.0","10.0","20.0","50.0","100.0"),lwd
=1,las= 1, 
     tck = -0.01, hadj = 0.4, cex.axis = .8) 
#y axis on the right - secondary (red labels) 
axis(side=4,at=c(L_05,U_05),labels = c(2.4,3.4),lwd=1,las= 1, 
     tck = -0.01, hadj = 0.4, cex.axis = .6,col.axis="red") 
 
###dashed lines 
segments(x0 = 0.000011, y0= U_005, x1 = 0.005, y1 = U_005, col = 
"gray40", lty = 2) 
segments(x0 = 0.000011, y0= L_005, x1 = 0.005, y1 = L_005, col = 
"gray40", lty = 2) 
segments(x0 = 0.005, y0= 0.00000001, x1 = 0.005, y1 = U_005, col = 
"gray40", lty = 2) 
 
segments(x0 = 0.05, y0= U_05, x1 = 0.14, y1 = U_05, col = "gray40", 
lty = 2) 
segments(x0 = 0.05, y0= L_05, x1 = 0.14, y1 = L_05, col = "gray40", 
lty = 2) 
segments(x0 = 0.05, y0= 0.00000001, x1 = 0.05, y1 = U_05, col = 
"gray40", lty = 2) 
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R code used to generate Figure 2: 
 
 
pow1=c(5:999)/1000   # power range for 0.005 tests 
pow2=c(50:999)/1000  # power range for 0.05 tests 
alpha=0.005 # test size 
pi0=5/6  # prior probability 
N=10^6  # doesn't matter 
 
 
#graph margins 
par(mai=c(0.8,0.8,0.1,0.1)) 
par(mgp=c(2,1,0))   
 
 
plot(pow1,alpha*N*pi0/(alpha*N*pi0+pow1*(1-pi0)*N),type='n',ylim = 
c(0,1), xlim = c(0,1.5), 
     xlab='Power                                      ', 
     ylab='False positive rate', bty="n", xaxt="n", yaxt="n") 
#grid lines 
segments(x0 = -0.058, y0 = 0, x1 = 1, y1 = 0,lty=1,col = "gray92") 
segments(x0 = -0.058, y0 = 0.2, x1 = 1, y1 = 0.2,lty=1,col = 
"gray92") 
segments(x0 = -0.058, y0 = 0.4, x1 = 1, y1 = 0.4,lty=1,col = 
"gray92") 
segments(x0 = -0.058, y0 = 0.6, x1 = 1, y1 = 0.6,lty=1,col = 
"gray92") 
segments(x0 = -0.058, y0 = 0.8, x1 = 1, y1 = 0.8,lty=1,col = 
"gray92") 
segments(x0 = -0.058, y0 = 1, x1 = 1, y1 = 1,lty=1,col = "gray92") 
 
 
lines(pow1,alpha*N*pi0/(alpha*N*pi0+pow1*(1-
pi0)*N),lty=1,col="blue",lwd=2) 
odd_1_5_1 = alpha*N*pi0/(alpha*N*pi0+pow1[995]*(1-pi0)*N) 
alpha=0.05 
pi0=5/6  
lines(pow2,alpha*N*pi0/(alpha*N*pi0+pow2*(1-
pi0)*N),lty=2,col="blue",lwd=2) 
odd_1_5_2 = alpha*N*pi0/(alpha*N*pi0+pow2[950]*(1-pi0)*N) 
 
 
alpha=0.05 
pi0=10/11 
lines(pow2,alpha*N*pi0/(alpha*N*pi0+pow2*(1-
pi0)*N),lty=2,col="red",lwd=2) 
odd_1_10_2 = alpha*N*pi0/(alpha*N*pi0+pow2[950]*(1-pi0)*N) 
alpha=0.005 
pi0=10/11 
lines(pow1,alpha*N*pi0/(alpha*N*pi0+pow1*(1-
pi0)*N),lty=1,col="red",lwd=2) 
odd_1_10_1 = alpha*N*pi0/(alpha*N*pi0+pow1[995]*(1-pi0)*N) 
 
alpha=0.05 
pi0=40/41 
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lines(pow2,alpha*N*pi0/(alpha*N*pi0+pow2*(1-
pi0)*N),lty=2,col="green",lwd=2) 
odd_1_40_2 = alpha*N*pi0/(alpha*N*pi0+pow2[950]*(1-pi0)*N) 
alpha=0.005 
pi0=40/41 
lines(pow1,alpha*N*pi0/(alpha*N*pi0+pow1*(1-
pi0)*N),lty=1,col="green",lwd=2) 
odd_1_40_1 = alpha*N*pi0/(alpha*N*pi0+pow1[995]*(1-pi0)*N) 
 
 
 
 
#customizing axes 
axis(side=2,at=c(-0.5,0,0.2,0.4,0.6,0.8,1.0),labels = 
c("","0.0","0.2","0.4","0.6","0.8","1.0"), 
     lwd=1,las= 1,tck = -0.01, hadj = 0.4, cex.axis = .8) 
axis(side=1,at=c(-0.5,0,0.2,0.4,0.6,0.8,1.0),labels = 
c("","0.0","0.2","0.4","0.6","0.8","1.0"), 
     lwd=1,las= 1, tck = -0.01, padj = -1.1, cex.axis = .8) 
 
 
 
legend(1.05,1,c("Prior odds = 1:40","Prior odds = 1:10","Prior odds 
= 1:5"),pch=c(15,15,15), 
       col=c("green","red","blue"), cex = 1) 
 
 
###############  Use these commands to add brackets in Figure 2 
 
library(pBrackets) 
 
 
#add text and brackets 
text(1.11,(odd_1_5_2+odd_1_40_2)/2, expression(paste(italic(P)," < 
0.05 threshold")), cex = 0.9,adj=0) 
text(1.11,(odd_1_5_1+odd_1_40_1)/2, expression(paste(italic(P)," < 
0.005 threshold")), cex = 0.9,adj=0) 
brackets(1.03, odd_1_40_1, 1.03, odd_1_5_1, h = NULL, ticks = 0.5, 
curvature = 0.7, type = 1, 
        col = 1, lwd = 1, lty = 1, xpd = FALSE) 
brackets(1.03, odd_1_40_2, 1.03, odd_1_5_2, h = NULL, ticks = 0.5, 
curvature = 0.7, type = 1, 
         col = 1, lwd = 1, lty = 1, xpd = FALSE) 
 
 
 
 	
